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ABSTRACT
Background and Objectives: In patients with fibromyalgia (FM) syndrome, stress and pain may chronically enhance sym-
pathetic activity, altering cardiovascular responses and inducing the arterial wall-stiffening process. We investigated arterial 
stiffness in FM patients using pulse wave velocity (PWV) and analyzed whether arterial stiffness was affected by the clinical 
parameters of FM. Subjects and Methods: This study included 108 female FM patients (51.5±8.9 years) without any 
known cardiovascular diseases and 76 healthy female controls (50.1±8.9 years). FM patients underwent a manual tender 
point survey for tender point counts, and completed the visual analogue scale (VAS) of pain and fibromyalgia impact ques-
tionnaire (FIQ), which were composed of a physical and feel score. Brachial-ankle pulse-wave velocity (baPWV) was mea-
sured with an automated device. The study participants were subdivided into 2 groups based on the sum of the FIQ score 
(group A: FIQ ≥50, group B: <50). Results: Patients with FM had significantly higher baPWV than the controls, and signif-
icant increase were noted in baPWV values of group A compared with those of group B. BaPWV showed a significant posi-
tive correlation (correlation coefficient=6.83, p=0.022) with severity of disease assessed by FIQ. Conclusion: The patients 
with FM showed significantly increased arterial stiffness, suggesting a pathophysiologic link between FM and endothelial 
dysfunction. This study provides a basis for clarifying the mechanism by which chronic pain syndrome is associated with an 
increased risk of vascular stiffness. (Korean Circ J 2011;41:596-602)
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Introduction
Fibromyalgia (FM) syndrome, characterized by chronic wi-
despread pain and discomfort, has diverse characteristics in-
cluding widespread musculoskeletal pain with discrete points 
of tenderness along with fatigue, sleep disturbance, cognitive 
dysfunction, and depressed mood. FM is considered to result 
from deregulation of pain modulator systems involving alter-
ed interactions between central and peripheral nervous sys-
tems and immune systems.
1) In patients with FM, stress and 
pain may chronically enhance sympathetic activity. Several 
lines of evidence indicate that sympathetic nervous system 
(SNS) function is altered in patients with FM.
2)3) SNS activity 
is an important determinant of the arterial wall-stiffening pro-
cess. Chronically enhanced sympathetic activity may alter 
cardiovascular responses and induce endothelial dysfunc-
tion. Using a nonhuman primate model of atherogenesis, it 
has been observed that psychosocial stress can alter the au-
tonomic balance towards a state of sympathetic arousal lead-
ing to the development of coronary artery disease (CAD), per-
haps through impairing endothelial function
4) and intensific-
ation of endothelium-mediated atherogenic processes.
5) In 
recent years, several studies have shown a decrease in endo-
thelial function in association with clinical depression or 
sub-clinical mood states or personality traits such as depres-
sion, anxiety, type A personality (hostility) or anger.
6)7)
Since stiffened arteries transmit pulse waves faster than the 
more elastic blood vessels, pulse wave velocity (PWV) is an Ji Hyun Lee, et al.   597
ideal indicator of arterial stiffness, and brachial artery pulse 
wave velocity (baPWV) is used to assess endothelial func-
tion by measuring the status of large and small arteries in 
the lower extremity.
8) We proposed that even in FM patients, 
we can observe a decrease in endothelial function, consider-
ing that psychological symptoms including anxiety, stress, 
and depression are often observed in FM.
9) This study inves-
tigated arterial stiffness in FM patients using baPWV, and 
analyzed whether arterial stiffness was affected by the clini-
cal parameters of FM, which were assessed by the fibromyal-
gia impact questionnaire (FIQ).
Subjects and Methods
Study population 
This study was conducted from January 2010 to December 
2010, and enrolled 108 consecutive female FM patients and 
76 healthy female controls that were matched to the FM pati-
ents by their age, blood pressure (BP), heart rate, height, cho-
lesterol and glucose levels. Diagnosis of FM was confirmed by 
a board-certified rheumatologist according to the guidelines 
outlined by the American College of Rheumatology.
10) Pati-
ents with history of major atherosclerotic risk factors includ-
ing hypertension and diabetes, history of CAD, congestive he-
art failure, history of neurological illness, smoking, obesity 
with body mass index above 26 and abnormal C-reactive pro-
tein (CRP) were excluded from the study. Controls were re-
cruited from the cardiology clinic and health screening cen-
ter and included subjects without chronic widespread pain. 
The study was approved by the Maryknoll medical center ins-
titutional review board and all subjects gave their written in-
formed consent.
Disease-specific evaluation
At each visit, patients with FM were asked to rate their cur-
rent level of pain on the 10 cm Visual Analog Scales (VASs, 0= 
no pain, 10=worst pain imaginable), a scale for rating pain 
intensity. Subjects then filled out the Korean Fibromyalgia 
Impact Questionnaire (kFIQ),
11) which is a validated, self-ad-
ministered test, scored out of 100, that evaluates physical func-
tion, work status, depression, anxiety, sleep, pain, stiffness, fa-
tigue, and well being. The study participants were also sub-
divided into 2 groups based on the sum of the FIQ score (gr-
oup A: FIQ ≥50, group B: <50). Subjects were then assessed 
for the number of positive tender points by digital palpation 
over the 18 characteristic tender point sites in the ACR cri-
teria for the diagnosis of FM. The subjects were requested to 
identify if a given point was painful as slow steady digital 
pressure was applied. The self-administered questionnaire, 
the Beck Depression Inventory (BDI) scale, and Brief Fati-
gue Inventory (BFI) scale, assessed symptoms of depression 
and fatigue, respectively. 
Measurement of arterial stiffness
Arterial stiffness was assessed by measuring brachial-an-
kle (ba) PWVs using an automatic waveform analyzer (VP-
1000; Colin Co., Komaki, Japan).
12) The VP-1000 simultane-
ously records pulse waves, BP (both arms and ankles), ankle-
brachial pressure index (ABI), electrocardiography, and heart 
sounds, as described elsewhere.
12)13) ABI was calculated by 
the ratio of the ankle systolic BP divided by the arm systolic 
BP, and the lower value of the ankle systolic BP was used for 
the calculation. For measuring baPWV, pulse waves obtain-
ed from the brachial and tibial arteries were recorded simul-
taneously, and the transmission time, which was defined as 
the time interval between the initial increase in brachial and 
tibial waveforms, was determined. The transmission distance 
from the arm to each ankle was calculated according to body 
height. The baPWV was automatically computed as the tr-
ansmission distance divided by the transmission time. All 
participants included in the present study had a normal ABI 
(>0.9). A high baPWV was defined as the gender-specific 
highest quartile of the values among the study subjects {ba-
PWV (the mean of the right and left values) ≥1,490 cm/s in 
females}. 
Statistical analysis
All data were expressed as mean±standard deviation. Data 
were analyzed using standard statistical software (Statistical 
Package for the Social Sciences package version 11.0, Chica-
go, IL, USA) and comparisons of all measurements were made 
with paired Student’s t-test for continuous variables and Pear-
son correlation test for correlation. Multivariate analysis was 
performed with logistic regression for the associations be-
tween demographic, atherosclerotic risk factors and baPWV. 
P<0.05 was considered statistically significant.
Results
Clinical characteristics of subjects
There were no significant differences between the FM and 
control groups in terms of age and the other parameters that 
are known to affect the PWV, including height, BP, heart rate 
and the total cholesterol levels (Table 1). There were also no 
significant differences in these variables except disease dura-
tion of the FM syndrome (p=0.007) (Table 2) between the 
groups A and B (Table 2). The value of tender point counts, 
pain VAS, FIQ scores, scales of anxiety, fatigue and depression 
were significantly higher in group A, as compared to group 
B (Table 2). 
Ankle-brachial pressure index and brachial artery 
pulse wave velocity values of patients and control 
group
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the FM patients and controls are shown in Table 1. The baP-
WV values of the FM and control groups (1,378.9±242.2 cm/s 
vs. 1,284.0±186.27 cm/s, p=0.005) were significantly differ-
ent (Table 1). Significant increases were also noted in baPWV 
values of group A compared with those of group B (1,438.9± 
281.7 vs. 1,330.4±184.3, p=0.013) (Table 3), and the same re-
sult was observed with the control group included (Table 3). 
The baPWV value of the subgroup (less than 130 mm Hg of 
systolic BP, and less than 200 mg/dL of total cholesterol, and 
less than 60 years of age) were also significantly different in 
patients with FM, as compared to controls (n=55, 1,338.4± 
228.6 vs. 1,241.9±181.9, p=0.005). 
Table 1. Baseline demographic characteristics of FM patients and controls 
FM patients (n=108) Control (n=76) p
Age (years) 51.5±8.9 50.1±8.9 0.32
BMI (kg/m
2) 23.4±2.8 23.3±3.2 0.72
Systolic BP (mm Hg) 123.9±13.6 126.2±12.8 0.56
Diastolic BP (mm Hg) 77.9±8.2 76.8±9.6 0.64
Heart rate (bpm) 73.4±7.9 74.2±7.3 0.45
Total cholesterol (mg/dL) 192.0±31.7 192.3±28.2 0.95
TSH (mIU/L) 01.82±1.35 01.95±1.27 0.51
Free T4 (pmol/L) 01.92±0.20 01.04±0.13 0.43
ABI 01.08±0.07 01.10±0.07 0.044
baPWV (cm/s) 1378.9±242.2 1284.0±186.2 0.005
High baPWV (number, %) 34 (31) 8 (11) 0.029
All values are described as mean±SD. FM: fibromyalgia syndrome, BMI: body mass index, BP: blood pressure, TSH: thyroid stimulating hor-
mone, ABI: ankle-brachial index, baPWV: brachial-ankle pulse wave velocity
Table 2. Comparison between the high (≥50) and the low FIQ group (<50) in FM patients
Group  A (n=53) Group B (n=55) p
Age (years )      52.9±9.70 51.9±8.90 0.300
Duration of disease (years) 7.3±6.9 3.5±4.9 0.001
BMI (kg/m
2) 21.5±1.30 22.8±3.20 0.320
Systolic BP (mm Hg) 125.9±11.80 126.7±12.30 0.730
Diastolic BP (mm Hg) 78.2±9.50 77.9±7.80 0.520
Heart rate (bpm) 72.8±11.3 70.7±9.80 0.580
Total cholesterol (mg/dL)       193.6±29.80 191.7±32.10 0.740
TSH (mIU/L)   1.83±1.22 1.82±1.46 0.950
Free T4 (pmol/L) 3.05±1.40 1.01±0.15 0.310
Tender point counts 14.64±1.880 13.10±1.930 <0.001
Pain VAS                            75.28±15.01 39.39±13.90 <0.001
FIQ   67.04±9.590 33.24±10.17 <0.001
Anxiety subscale 64.91±16.60 32.58±19.63 <0.001
Fatigue subscale  80.38±15.31 45.27±19.80 <0.001
Depression subscale  61.89±18.71 31.82±15.48 <0.001
All values are described as mean±SD. FIQ: Fibromyalgia Impact Questionnaire, FM: fibromyalgia syndrome, BMI: body mass index, BP: blood 
pressure, HR: heart rate, TSH: thyroid stimulating hormone, VAS : Visual Analog Scale
Table 3. Arterial stiffness parameters of subgroup A (FIQ ≥50) and B (FIQ <50) of FM subjects
Group A (n=53) Group B (n=55) p (A vs. B) Control (n=76) p (A vs. control) p (B vs. control)
ABI 01.07±0.08 01.08±0.07 0.680 01.10±0.07 0.047 0.16
baPWV (cm/s) 1438.9±281.7 1321.1±181.4 0.012 1284.0±186.2 0.001 0.17
High PWV (%) 20 (38) 10 (18) 0.018 8 (11) 0.006 0.34
All values are described as mean±SD. FIQ: Fibromyalgia Impact Questionnaire, FM: fibromyalgia syndrome, ABI: ankle-brachial index, 
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Fig. 1. Regression analysis between parameters of fibromyalgia functional status and brachial-ankle pulse wave velocity (baPWV). FIQ (A), 
pain VAS (B) and subscales of depression (C), anxiety (D), and fatigue (E) showed significant effect on baPWV. FIQ: fibromyalgia impact 
questionnaire, VAS: visual analog scales.
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Correlation of the brachial artery pulse wave velocity 
values with clinical features in fibromyalgia patients
BaPWV showed a significant positive correlation with 
FIQ (r=0.29, p=0.003) (Fig. 1A) using Pearson’s correlation 
coefficient. Significant positive correlations were also found-
ed between baPWV and parameters of physical and emotion-
al stress such as pain VAS, depression, anxiety, and fatigue sub-
scales (Fig. 1). Multiple regression analysis was used to ad-
just for any potential confounding influences of age, chole-
sterol, the duration of the disease and the clinical variables of 
FM. This relationship remained highly significant on multiva-
riate regression analysis to determine the independent con-
tribution FIQ score to baPWV (adjusted r=0.194, p=0.022). 
However, grade of depression, fatigue scale, pain VAS, and 
tender point counts exhibited no significant effect on baPWV 
(Table 4). The proportion of patients with high baPWV was 
significantly greater in the patients group compared to the 
control, and group A compared to group B (all p<0.01). 
Discussion
For over a century, it has been thought that abnormal acti-
vity of the SNS may be involved in the pathogenesis of ch-
ronic pain syndromes. This assumption was based on the 
observation that pain is spatially correlated with signs of au-
tonomic dysfunction and that blocking the efferent sympa-
thetic supply to the affected region relieves the pain.
14) Several 
mechanisms of endothelial damage concomitant with, or 
downstream to, SNS activation have been proposed. Recent 
data suggest that elevated systemic levels of catecholamines 
are central to the pathophysiology of these kinds of disor-
ders.
15) The mechanisms of catecholamine-induced endo-
thelial damage, however, are thought to be multifactorial, 
including persistent activation of calcium channels, membr-
ane damage, and microvascular spasms.
16) Microvascular en-
dothelial dysfunction can sensitize the coronary circulation 
to the vasoconstrictor effects of catecholamines.
17) Microvas-
cular spasm and cardiac syndrome X are also associated with 
female predominance, particularly in the postmenopausal 
years, congruent to the gender differences seen in transient 
left ventricular (LV) dysfunction.
18) Previously, we examined 
myocardial function in patients with FM with 2-dimension-
al strain echocardiography and assessed the relationship be-
tween clinical parameters of FM and myocardial function.
19) 
In that study, we suggested that the severity of distress in pati-
ents with FM might be correlated with LV function and ch-
ronic distress might reduce myocardial longitudinal defor-
mation by possible microcirculatory impairment or en-
dothelial dysfunction due to excessive activation of the SNS. 
At that time, we expected that decrease in endothelial func-
tion could be observed in patients with FM, and in the recent 
study,
20) we evaluated endothelial dysfunction reflected by 
an impaired brachial artery flow-mediated dilatation (FMD) 
response in patients with FM. We showed that FM patients 
exhibited decreased endothelial-dependent vasodilatation 
and endothelial-independent vasodilatation, and these pa-
rameters were in parallel with FIQ and pain parameters as 
well. Because FMD is endothelium-dependent and is largely 
controlled by the release of endothelial nitric oxide (NO),
21) an 
impairment of endothelium-dependent FMD suggests that 
there is decreased endothelial NO activity, which has been 
found to directly regulate large artery stiffness in vivo.
22) 
In the present study, we compared ABI and baPWV in fe-
male FM patients and evaluated the factors affecting arterial 
stiffness in patients with FM. ABI was reported to be a good 
marker for atherosclerosis and useful in the diagnosis of pe-
ripheral artery occlusive disease.
23)24) baPWV has been re-
ported as a good marker for arterial stiffness.
25) The results of 
smaller studies have shown that baPWV was an independent 
predictor of cardiovascular death and cardiac events in elderly 
persons in the community as well as in patients with CAD.
26)27) 
Although data on the value of the baPWV for the prediction 
Table 4. Multiple regression analysis between FM functional parameters and vascular parameters
ABI baPWV
Coefficient r p  Coefficient r p 
Age 0.0020 0.260 0.012 12.50 0.51 <0.0001
Cholesterol 0.0001 0.110 0.560 -0.17 0.05 <0.790
Duration -0.0004 -0.030 0.730 3.51 0.28 <0.310
Pain VAS -0.0004 -0.150 0.390 -2.63 0.21 <0.220
FIQ -0.0280 -0.120 0.730 6.83 0.29 <0.022
FM TP 0.0010 -0.001 0.770 -14.30 0.07 <0.180
Fatigue 0.0007 -0.050 0.250 -2.03 0.20 <0.200
Depression 0.0001 -0.090 0.850 1.52 0.25 <0.440
Anxiety -0.0003 -0.090 0.720 0.66 0.27 <0.730
FM: fibromyalgia syndrome, ABI: ankle-brachial index, baPWV: brachial-ankle pulse wave velocity, VAS: Visual Analog Scales, FIQ: fibro-
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of cardiovascular events is limited, the baPWV is easy to mea-
sure and has the potential for screening applications.
28) The 
ABI and baPWV measurement can be conducted at low cost 
using simple techniques and is non-invasive and not operator-
dependent, like carotid ultrasound. In our study, FM patients 
showed decreased ABI values compared to the controls, but 
ABI showed no correlation with clinical parameters of FM, 
which suggests that the severity of disease is not associated 
with arterial stenosis. We found that the proportion of high 
baPWV was significantly higher in FM patients and baPWV 
was related to age and parameters of physical and emotional 
stress such as pain VAS, FIQ score, subscales of depression, 
anxiety, and fatigue. Increased arterial stiffness in FM patients 
suggested a pathophysiologic link between FM and endothe-
lial dysfunction.
There were several limitations in our study. This study was 
performed in women, and the selected study population can 
be a limitation. However, male FM patients are more prone 
to smoking, old age, and dyslipidemia than female FM pa-
tients, which were well known confounding factors on arte-
rial stiffness. Besides considering the gender effect itself on 
arterial stiffness, we wanted to evaluate the pure contribu-
tion of disease severity on arterial stiffness, so we excluded the 
male population. Second, we did not account for the men-
strual cycle of patients during this study. Previous data has 
suggested that there are no effects of the different hormonal 
phases of the menstrual cycle on cardiovascular variables 
such as heart rate variability (HRV) and baroreflex sensitivity 
(BRS). Leicht et al.
29) reported no alteration of HRV during 
different time points in a regular menstrual cycle. Similarly, 
Cooke et al.
30) reported no alteration of BRS during different 
time points in a regular menstrual cycle. However, it is pos-
sible that this difference masked some additional discrepan-
cies between the women with FM and the healthy controls. 
Finally, our participants were on a variety of medications. It 
is likely that antidepressants may have some effect on auto-
nomic function, but we did not account for medication since 
the sample size was too small. Therefore, the findings of this 
study are only preliminary data, and large surveys with sam-
pling of subjects by strict medical examination will be neces-
sary in the future.
In conclusion, based on our findings, female FM patients 
had significantly increased arterial stiffness when compared 
with the healthy controls. This study provides a basis for clari-
fying the mechanism by which FM is associated with in-
creased risk of vascular stiffness, but longitudinal studies em-
ploying a larger sample population are required to determine 
the pathophysiologic and prognostic implications of increas-
ed arterial stiffness in FM. 
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